Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women

Mickaël Hiligsmann; Wafa Ben Sedrine; Olivier Bruyère; Jean-Yves Reginster

Back

Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women

Conference proceeding

Peer reviewed

Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women

Mickaël Hiligsmann, Wafa Ben Sedrine, Olivier Bruyère and Jean-Yves Reginster

Osteoporosis International, 23 (Suppl. 2), S312-313 (2012-03); European Congress on Osteoporosis and Osteoarthritis IOF-ECCEO12, Bordeaux, France [FR], du 21 mars 2012 au 24 mars 2012

03/2012

Abstract

Human health sciences

Public health, health care sciences & services

Rheumatology

Rhumatologie

Santé publique, services médicaux & soins de santé

Sciences de la santé humaine

Metrics

1 Record Views

Details

Title: Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women
Creators - without role: Mickaël Hiligsmann
Wafa Ben Sedrine
Olivier Bruyère
Jean-Yves Reginster
Conference: Osteoporosis International, 23 (Suppl. 2), S312-313 (2012-03); European Congress on Osteoporosis and Osteoarthritis IOF-ECCEO12, Bordeaux, France [FR], du 21 mars 2012 au 24 mars 2012
Publisher: Springer Science & Business Media B.V
Identifiers: 9951491108331
Academic Unit: King Saud University
Language: English
Resource Type: Conference proceeding